how much is in a vial of tirzepatide Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity More effective than semaglutide Tirzepatide 60mg/3mL (20mg/mL) | Pipeline

What he has found is that most

Novo Nordisk's investment in prescriber education and patient support programs, combined with copay assistance initiatives that reduce out-of-pocket costs for commercially insured patients, has sustained Ozempic's prescription volume even as the market has expanded

Caution is especially important in people with a history of pancreatitis, significant gastrointestinal disease, severe dehydration risk, certain endocrine tumor syndromes, or medication regimens that may interact with appetite-suppressing or glucose-lowering therapies

The GLP-1 companion-supplement market was valued at roughly $735 million in the US in 2025 and is projected to keep growing at a double-digit annual rate through the early 2030s